Form 4: IonQ CFO Sells Over $2.2 Million in Shares Under Pre-Arranged Plan
Insider Transaction Report
IonQ's Chief Financial Officer, Thomas G. Kramer, sold 47,478 shares of common stock for approximately $2.26 million under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Thomas G. Kramer, Chief Financial Officer of IonQ, Inc., sold 47,478 shares of the company's common stock.
- The transaction occurred on July 21, 2025, and was executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.
- The shares were sold at a weighted average price of $47.7004 per share, with individual transaction prices ranging from $47.70 to $47.72.
- The total value of the shares sold is approximately $2,264,600.
- Following the reported transaction, Thomas G. Kramer beneficially owns 555,656 shares directly and 5 shares indirectly through a child, totaling 555,661 shares.
Sentiment
Score: 4
Explanation: While executed under a Rule 10b5-1 plan, the sale of over $2.2 million in common stock by the Chief Financial Officer could be perceived as a slight negative signal regarding management's conviction, even if pre-scheduled.
Positives
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating the sale was not based on new material non-public information and provides transparency regarding the executive's trading intentions.
Negatives
- Chief Financial Officer Thomas G. Kramer sold 47,478 shares of IonQ common stock, representing a significant reduction in his direct holdings.
- The sale value of approximately $2.26 million could be interpreted by some investors as a lack of strong conviction in the company's near-term share price appreciation.
Risks
- No specific risks are detailed in this Form 4 filing, as it primarily reports an insider transaction.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This Form 4 filing details an insider transaction and does not provide information related to broader industry trends or competitors.
Stakeholder Impact
- Shareholders may note the sale of shares by a key executive, though the pre-arranged nature of the transaction under a Rule 10b5-1 plan suggests it is not based on new material non-public information. This could still lead to some negative sentiment or questions about executive confidence.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 07/21/2025 | Date of the common stock transaction (sale). |
| 07/23/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe filing details a significant insider stock sale by the CFO, even though it was pre-scheduled under a Rule 10b5-1 plan. While the plan mitigates concerns about opportunistic trading, the substantial value of the sale (over $2.2 million) could be viewed as a slight negative signal regarding management's conviction. However, without additional context on the company's fundamentals or broader market conditions, this single transaction primarily serves as a data point for investors, supporting a 'hold' recommendation rather than a strong buy or sell.
Keywords
IonQ, IONQ, insider trading, Form 4, stock sale, CFO, Thomas G. Kramer, Rule 10b5-1, quantum computing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.